Ledger.Open graph →

SEC Form D · Amendment · filed November 27, 2019

Adaptive Phage Therapeutics, Inc

Offering

$7.0M

Sold

$7.0M

Exemption

Rule 506(b)

Industry

Pharmaceuticals

Location

GAITHERSBURG, MD

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (9)

Gregory L. Merril · Gaithersburg, MDExec · Director Raymond L. Martz · Gaithersburg, MDDirector Carl L. Merril · Gaithersburg, MDExec · Director Thomas Spicer · Luxembourg, LuxembourgExec · Director Maren Steinberg · DENVER, COExec · Director Ashley Granata · Los Angeles, CADirector Guillermo Guefen · Houston, TXExec · Director Nick P. Steinsberger · Tulsa, OKExec · Director Robert Ziehl · Portland, ORDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗